Markets:

Overview

News

Currencies

International

Treasuries

Codex DNA, Inc. - Common Stock (NQ:DNAY)

N/A UNCHANGED

Last Price Updated: 3:59 PM EST, Jan 3, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Codex DNA, Inc. - Common Stock

< Previous 1 2 3 Next >

Mid-Afternoon Market Update: Dow Drops 1%; Snap One Shares Plunge ↗

March 23, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 350 points on Wednesday. The Dow traded down 1.05% to 34,442.47 while the NASDAQ fell 1.09...

Via Benzinga

Mid-Day Market Update: Nasdaq Turns Positive; 4D pharma Shares Jump ↗

March 23, 2022

The Nasdaq Composite turned higher midway through trading on Wednesday. The Dow traded down 0.69% to 34,566.59 while the NASDAQ rose 0.28% to 14,148.16. The S&P also fell...

Via Benzinga

38 Stocks Moving In Wednesday's Mid-Day Session ↗

March 23, 2022

Gainers Allego N.V. (NYSE: ALLG) shares jumped 158.5% to $21.41 after the company announced the completion of its merger agreement with Spartan Acquisition Corp., which resulted...

Via Benzinga

Looking Into Codex DNA's Return On Capital Employed ↗

March 23, 2022

Benzinga Pro data, Codex DNA (NASDAQ:DNAY) reported Q4 sales of $3.08 million. Earnings fell to a loss of $12.49 million, resulting in a 27.15% decrease from last quarter. In Q3...

Via Benzinga

Mid-Morning Market Update: Markets Open Lower; General Mills Posts Upbeat Earnings ↗

March 23, 2022

U.S. stocks opened on downbeat note this morning, with the Dow Jones dropping more than 250 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.80%...

Via Benzinga

Earnings Scheduled For March 22, 2022 ↗

March 22, 2022

Companies Reporting Before The Bell • GDS Holdings (NASDAQ:GDS) is projected to report quarterly loss at $0.18 per share on revenue of $338.69 million. • HUYA (...

Via Benzinga

45 Stocks Moving In Friday's Mid-Day Session ↗

March 18, 2022

Gainers Grom Social Enterprises, Inc. (NASDAQ: GROM) jumped 62.4% to $1.5500. DiDi Global Inc. (NYSE: DIDI) shares climbed 46% to $3.73. Kidpik Corp. (NASDAQ: PIK) shares...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 16, 2022

Gainers

Via Benzinga

47 Biggest Movers From Yesterday ↗

February 08, 2022

Gainers Nuvectis Pharma, Inc. (NASDAQ: NVCT) shares surged 144.6% to close at $7.95 on Monday. The company, on Friday, priced its IPO at $5 per share. Anghami Inc. (NASDAQ: ANGH...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 07, 2022

Gainers Agile Therapeutics (NASDAQ:AGRX) ...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 07, 2022

Gainers Nuvectis Pharma (NASDAQ:NVCT) stock moved upwards by 132.3% to $7.55 during Monday's regular session. The current volume of 17.0 million shares is 2307.5% of...

Via Benzinga

32 Stocks Moving In Monday's Mid-Day Session ↗

February 07, 2022

Gainers Nuvectis Pharma, Inc. (NASDAQ: NVCT) jumped 191.2% to $9.47. The company, on Friday, priced its IPO at $5 per share. Anghami Inc. (NASDAQ: ANGH) shares jumped 51% to $18....

Via Benzinga

Pfizer Continues Its Covid Makeover: What's Next For This Hot Stock? ↗

January 13, 2022

How the pandemic continued a transformation Pfizer says began years ago.

Via Investor's Business Daily

52 Biggest Movers From Friday ↗

January 18, 2022

Gainers Splash Beverage Group, Inc. (NASDAQ: SBEV) shares gained 118.9% to settle at $4.18 on Friday. Splash Beverage recently announced it has received authorization to sell its...

Via Benzinga

Biotech Bloodbath Continues Despite Gene-Editing Deals For Pfizer, Bayer ↗

January 10, 2022

Pfizer and Bayer inked deals with several companies in gene-editing.

Via Investor's Business Daily

Why Codex DNA Shares Are Trading Higher Today? ↗

January 10, 2022

Pfizer Inc (NYSE: PFE) has signed on two partners in an effort to become an mRNA powerhouse. Pfizer will offer milestone payments of over $100 million to ...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 31, 2021

Gainers Nutriband (NASDAQ:NTRB) stock moved upwards by 186.7% to $11.21 during Friday's regular session. The current volume of 101.5 million shares is 7226.8% of...

Via Benzinga

63 Biggest Movers From Yesterday ↗

December 31, 2021

Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares surged 93.2% to close at $1.70 on Thursday. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its...

Via Benzinga

45 Biggest Movers From Yesterday ↗

December 30, 2021

Gainers Puxin Limited (NYSE: NEW) shares surged 80% to close at $0.54 on Wednesday after reporting results for the second quarter. United Time Technology Co., Ltd. (NASDAQ: UTME...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 29, 2021

Gainers Cognition Therapeutics (NASDAQ:CGTX

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 29, 2021

Gainers Biofrontera (NASDAQ:

Via Benzinga

26 Stocks Moving In Wednesday's Mid-Day Session ↗

December 29, 2021

Gainers Puxin Limited (NYSE: NEW) jumped 100.5% to $0.6016 after reporting results for the second quarter. ShiftPixy, Inc. (NASDAQ: PIXY) climbed 38.4% to $1.55 after surging 43...

Via Benzinga

54 Biggest Movers From Thursday ↗

December 27, 2021

Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 23, 2021

Gainers Pasithea Therapeutics (NASDAQ:

Via Benzinga

Codex DNA, Inc. (DNAY) Q3 2021 Earnings Call Transcript ↗

November 10, 2021

DNAY earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance ↗

November 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...

Via Benzinga

Codex DNA Clocks Q3 Sales Growth Of 75%; Acquires Eton Bioscience For $13M ↗

November 10, 2021

Codex DNA Inc's (NASDAQ: DNAY) Q3 revenues increased 75% Y/Y to $2.8 million. The total fell short of the consensus Wall Street estimate of $2.93 million. Q3 was...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs ↗

September 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (...

Via Benzinga

48 Biggest Movers From Yesterday ↗

September 21, 2021

Gainers Edesa Biotech, Inc. (NASDAQ: EDSA) shares climbed 102.7% to settle at $11.92 on Monday after the company disclosed Phase 2 data of its monoclonal antibody in hospitalized...

Via Benzinga

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data ↗

September 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Codex DNA, Inc. - Common Stock (NQ:DNAY)

All News about Codex DNA, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today